MyHealios is a brand that is dedicated to transforming neuroscience through digital biomarkers. They provide patients and doctors with mobile health platforms and digital biomarkers to improve patient diagnosis, treatment, research, and clinical practice. With their innovative mobile platforms powered by artificial intelligence, Healios AG aims to empower healthcare professionals and clinical research teams, establishing a new standard in precision neuroscience.

Healios AG is a medical device software manufacturer that specializes in finding solutions in clinical research and patient monitoring through innovative digital technologies. They offer novel, validated, and patented digital biomarkers that measure changes in motor and cognitive functions in patients with neurological disorders with unprecedented sensitivity. These biomarkers not only advance pharmacological research but also revolutionize clinical practice.

By working closely with patients, caregivers, and healthcare professionals, Healios AG identifies and addresses the challenges they face, ultimately improving the patient-healthcare professional relationship and creating opportunities for novel insights and timely changes in diagnosis and disease management. With a strong track record of collaborations and achievements, Healios AG is at the forefront of multiple sclerosis research and aims to establish a new generation of endpoints for drug research and clinical practice. To learn more about their software medical device solution and how it can transform neuroscience, reach out to Healios AG today